Pfizer COVID-19 vaccine partially protective against Omicron - Bloomberg News

|
PrintFind an error? Report us
The Omicron variant of the coronavirus can partially evade the protection from Pfizer Inc and partner BioNTech's COVID-19 vaccine, Bloomberg News reported on Tuesday, citing the research head of a laboratory at Africa Health Research Institute in South Africa.
Its evasion is not complete and a booster shot could provide additional protection, according to the report
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""